150 related articles for article (PubMed ID: 20515759)
1. Smad anchor for receptor activation (SARA) in TGF-beta signaling.
Tang WB; Ling GH; Sun L; Liu FY
Front Biosci (Elite Ed); 2010 Jun; 2(3):857-60. PubMed ID: 20515759
[TBL] [Abstract][Full Text] [Related]
2. Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype.
Runyan CE; Hayashida T; Hubchak S; Curley JF; Schnaper HW
J Biol Chem; 2009 Sep; 284(37):25181-9. PubMed ID: 19620243
[TBL] [Abstract][Full Text] [Related]
3. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells.
Runyan CE; Schnaper HW; Poncelet AC
J Biol Chem; 2005 Mar; 280(9):8300-8. PubMed ID: 15613484
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.
Zhao BM; Hoffmann FM
Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010
[TBL] [Abstract][Full Text] [Related]
5. Focal adhesion molecule Kindlin-1 mediates activation of TGF-β signaling by interacting with TGF-βRI, SARA and Smad3 in colorectal cancer cells.
Kong J; Du J; Wang Y; Yang M; Gao J; Wei X; Fang W; Zhan J; Zhang H
Oncotarget; 2016 Nov; 7(46):76224-76237. PubMed ID: 27776350
[TBL] [Abstract][Full Text] [Related]
6. Smad Anchor for Receptor Activation Regulates High Glucose-Induced EMT via Modulation of Smad2 and Smad3 Activities in Renal Tubular Epithelial Cells.
Tang WB; Ling GH; Sun L; Zhang K; Zhu X; Zhou X; Liu FY
Nephron; 2015; 130(3):213-20. PubMed ID: 26159183
[TBL] [Abstract][Full Text] [Related]
7. The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-beta/Smad signalling.
Itoh F; Divecha N; Brocks L; Oomen L; Janssen H; Calafat J; Itoh S; Dijke Pt Pt
Genes Cells; 2002 Mar; 7(3):321-31. PubMed ID: 11918675
[TBL] [Abstract][Full Text] [Related]
8. SMURF2 and SMAD7 induce SARA degradation via the proteasome.
Wojtowicz S; Lee S; Chan E; Ng E; Campbell CI; Di Guglielmo GM
Cell Signal; 2020 Aug; 72():109627. PubMed ID: 32283253
[TBL] [Abstract][Full Text] [Related]
9. The FYVE domain of Smad Anchor for Receptor Activation (SARA) is required to prevent skin carcinogenesis, but not in mouse development.
Chang HM; Lin YY; Tsai PC; Liang CT; Yan YT
PLoS One; 2014; 9(8):e105299. PubMed ID: 25170969
[TBL] [Abstract][Full Text] [Related]
10. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.
Tsukazaki T; Chiang TA; Davison AF; Attisano L; Wrana JL
Cell; 1998 Dec; 95(6):779-91. PubMed ID: 9865696
[TBL] [Abstract][Full Text] [Related]
11. ERBIN is a new SARA-interacting protein: competition between SARA and SMAD2 and SMAD3 for binding to ERBIN.
Sflomos G; Kostaras E; Panopoulou E; Pappas N; Kyrkou A; Politou AS; Fotsis T; Murphy C
J Cell Sci; 2011 Oct; 124(Pt 19):3209-22. PubMed ID: 21878490
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
13. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
[TBL] [Abstract][Full Text] [Related]
14. Smad Anchor for Receptor Activation and Phospho-Smad3 Were Upregulated in Patients with Temporal Lobe Epilepsy.
Zhang W; Du Y; Zou Y; Luo J; Lü Y; Yu W
J Mol Neurosci; 2019 May; 68(1):91-98. PubMed ID: 30847724
[TBL] [Abstract][Full Text] [Related]
15. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
16. Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms.
Neil JR; Johnson KM; Nemenoff RA; Schiemann WP
Carcinogenesis; 2008 Nov; 29(11):2227-35. PubMed ID: 18725385
[TBL] [Abstract][Full Text] [Related]
17. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling.
Nakano N; Maeyama K; Sakata N; Itoh F; Akatsu R; Nakata M; Katsu Y; Ikeno S; Togawa Y; Vo Nguyen TT; Watanabe Y; Kato M; Itoh S
J Biol Chem; 2014 May; 289(18):12680-92. PubMed ID: 24627487
[TBL] [Abstract][Full Text] [Related]
18. TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2.
Hayes S; Chawla A; Corvera S
J Cell Biol; 2002 Sep; 158(7):1239-49. PubMed ID: 12356868
[TBL] [Abstract][Full Text] [Related]
19. PP1 binds Sara and negatively regulates Dpp signaling in Drosophila melanogaster.
Bennett D; Alphey L
Nat Genet; 2002 Aug; 31(4):419-23. PubMed ID: 12134149
[TBL] [Abstract][Full Text] [Related]
20. Analysis of transforming growth factor β signaling in chronic rhinosinusitis.
Li YC; An YS; Wang T; Zang HR
Chin Med J (Engl); 2013; 126(17):3340-3. PubMed ID: 24033961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
